Atypical antipsychotic-induced diabetes mellitus: An update on epidemiology and postulated mechanisms

Internal Medicine Journal

Volumn 38, Issue 7, 2008, Pages 602-606

  Buchholz, S ^a   Morrow, A F ^b   Coleman, P L ^c  

^a NAMBOUR GENERAL HOSPITAL   (Australia)

^b Mona Vale Hospital   (Australia)

^c Manly District Hospital   (Australia)

Author keywords

Atypical antipsychotic; Diabetes mellitus; Diabetic ketoacidosis; Hyperosmolar hyperglycaemic syndrome

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; OLANZAPINE; RISPERIDONE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE REPORT; DIABETES MELLITUS; DISEASE COURSE; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALAISE; MALE; PARANOID SCHIZOPHRENIA; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; RELAPSE; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; UREMIA; URINALYSIS; WEIGHT REDUCTION;

ADULT; ANTIPSYCHOTIC AGENTS; BLOOD GLUCOSE; DIABETES MELLITUS; HUMANS; MALE;

EID: 48249121125     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2008.01712.x     Document Type: Article

References (29)

1. Koller EA, Doraiswamy PM. Olanzapine-associated diabetes mellitus. Pharmacotherapy 2002 22 : 841 52.
2. FDA Patient Safety News. Warning about hyperglycemia and atypical antipsychotic drugs, show 28. 2004 Jun cited 2007 Apr. Available from URL : http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/printer.cfm?id=229
3. Braceland FJ, Meduna LJ, Vaichulis JA. Delayed action of insulin in schizophrenia. Am J Psychiatry 1945 102 : 108 10.
4. Ryan MCM, Collins P, Thakore JH. Impaired fasting glucose and elevation of cortisol in drug-naïve first-episode schizophrenia. Am J Psychiatry 2003 160 : 284 9.
5. Gough SCL, O'Donovan MC. Clustering of metabolic co-morbidity in schizophrenia: a genetic contribution. J Psychopharmacol 2005 19 : 47 55.
6. Sacchetti E, Turrina C, Parrinello G, Brignoli O, Stefanini G, Mazzaglia G. Incidence of diabetes in a general practice population: a database cohort study on the relationship with haloperidol, olanzapine, risperidone or quetiapine exposure. Int Clin Psychopharmacol 2005 20 : 33 7.
7. Jin H, Meyer JM, Jeste DV. Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases. Ann Clin Psychiatry 2002 14 : 59 64.
8. Meatherall R, Younes J. Fatality from olanzapine-induced hyperglycemia. J Forensic Sci 2002 47 : 893 6.
9. Henderson DC, Cagliero E, Copeland P, Louie PM, Borba CP, Fan X et al. Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics. J Clin Psychiatry 2007 68 : 533 41.
10. Meyer JM. Effects of atypical antipsychotics on weight gain and serum lipid levels. J Clin Psychiatry 2001 62 : 27 34.
11. Heiskanen T, Niskanen L, Lyytikainen R, Saarinen PI, Hintikka J. Metabolic syndrome in patients with schizophrenia. J Clin Psychiatry 2003 64 : 575 9.
12. Gilles M, Wilke A, Kopf D, Nonell A, Lehner H, Deuschle M. Antagonism of the serotonin (5-HT)-2 receptor and insulin sensitivity: implications for atypical antipsychotics. Psychosom Med 2005 67 : 748 51.
13. Tsuchiyama N, Ando H, Ota T, Sakurai M, Takamura T. Modulating effects of olanzapine on the development of diabetic ketoacidosis. Diabet Med 2004 21 : 300 301.
14. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signalling cascade. Diabetes 1999 48 : 1270 74.
15. Elias CF, Aschkenasi C, Lee C, Kelly J, Ahima RS, Bjorbaek C et al. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 1999 23 : 775 86.
16. Baptista T, Lacruz A, de Mendoza S, Mendoza Guillen JM, Silvera R, Angeles F et al. Body weight gain after administration of antipsychotic drugs: correlation with leptin, insulin and reproductive hormones. Pharmacopsychiatry 2000 33 : 81 8.
17. Melkerson KI, Hulting AL, Brismar KE. Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J Clin Psychiatry 2000 61 : 742 9.
18. 2C receptor gene. Nat Med 1998 4 : 1152 6.
19. 2c serotonin receptors. Nature 1995 374 : 542 6.
20. 2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis. Pharmacogenet Genomics 2005 15 : 195 200.
21. Schaffhauser AO, Madiehe AM, Braymer HD, Bray GA, York DA. Effects of a high-fat diet and strain on hypothalamic gene expression in rats. Obes Res 2002 10 : 1188 96.
22. Avella J, Wetli CV, Wilson JC, Katz M, Hahn T. Fatal olanzapine-induced hyperglycemic ketoacidosis. Am J Forensic Med Pathol 2004 25 : 172 5.
23. Henderson DC, Caliero E, Gray C, Nasrallah RA, Hayden DL, Schoenfeld DA et al. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study. Am J Psychiatry 2000 157 : 975 81.
24. Moller AM, Dalgaard LT, Pociot F, Nerup J, Hansen T, Pedersen O. Mutations in the hepatocyte nuclear factor 1-alpha gene in Caucasian families originally classified as having type 1 diabetes. Diabetologia 1998 12 : 1528 31.
25. Merrick T, Felo J, Jenkins A. Tissue distribution of olanzapine in a postmortem case. Am J Forensic Med Pathol 2001 22 : 270 74.
26. Chung I, Bresnick E. Identification of positive and negative regulatory elements of the cytochrome P4501A2 gene. Arch Biochem Biophys 1997 338 : 220 26.
27. Wang H, Maechler P, Hagenfeldt KA, Wollheim CB. Dominant-negative suppression of HNF-1 alpha function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic b-cell line. EMBO J 1998 17 : 6701 13.
28. Koller EA, Schneider B, Bennett K, Dubitsky G. Clozapine-associated diabetes. Am J Med 2001 111 : 716 23.
29. Western Australia Psychotropic Drugs Committee. Version 3. Department of Health 2006 Aug cited 2007 Apr. Available from URL : http://www.watag.org.au/ wapdc/docs/Antipsychotic_Guidelines_Aug06.pdf